"The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.
Simponi works by blocking tumor necrosis factor (TNF), which plays an important"...
- Patient Information:
Details with Side Effects
- Instruct patients to swallow the Asacol HD (mesalamine delayed-release tablets, oral) tablets whole, taking care not to break, cut, or chew the tablets, because the outer coating is an important part of the delayed-release formulation.
- Inform patients that if they are switching from a previous oral mesalamine therapy to Asacol HD they should discontinue their previous oral mesalamine therapy and follow the dosing instructions for Asacol HD (mesalamine delayed-release tablets, oral) . Inform patients that they should not substitute one Asacol HD tablet with two Asacol 400 mg tablets [see Dosage Forms and Strengths and CLINICAL PHARMACOLOGY].
- Inform patients that intact, partially intact, and/or tablet shells have been reported in the stool. Instruct patients to contact their physician if this occurs repeatedly.
- Instruct patients to protect Asacol HD (mesalamine delayed-release tablets, oral) tablets from moisture. Instruct patients to close the container tightly and to leave any desiccant pouches present in the bottle along with the tablets.
Last reviewed on RxList: 10/23/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Asacol HD Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.